Get started
Mayne Pharma Ltd.Mayne Pharma Ltd.Mayne Pharma Ltd.

Mayne Pharma Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

MAYNF chart

Key stats

Market capitalization
‪393.50 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.99USD
Net income (FY)
‪−210.74 M‬USD
Revenue (FY)
‪122.27 M‬USD
Shares float
‪61.54 M‬
Beta (1Y)
0.07

About Mayne Pharma Ltd.

Sector
Health Technology
CEO
Shawn Patrick O'Brien
Headquarters
Salisbury
Website
maynepharma.com
Founded
2005
ISIN
AU000000MYX0
FIGI
BBG0046WCK79
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MAYNF is 4.54 USD — it has increased by 1.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Mayne Pharma Ltd. stocks are traded under the ticker MAYNF.
Mayne Pharma Ltd. is going to release the next earnings report on Aug 23, 2024. Keep track of upcoming events with our Earnings Calendar.
MAYNF stock is 1.10% volatile and has beta coefficient of 0.07. Check out the list of the most volatile stocks — is Mayne Pharma Ltd. there?
MAYNF earnings for the last quarter are −1.34 USD per share, whereas the estimation was −0.38 USD resulting in a −251.75% surprise. The estimated earnings for the next quarter are −0.31 USD per share. See more details about Mayne Pharma Ltd. earnings.
Mayne Pharma Ltd. revenue for the last quarter amounts to ‪54.88 M‬ USD despite the estimated figure of ‪115.22 M‬ USD. In the next quarter revenue is expected to reach ‪109.61 M‬ USD.
Yes, you can track Mayne Pharma Ltd. financials in yearly and quarterly reports right on TradingView.
MAYNF stock has risen by 1.11% compared to the previous week, the month change is a 1.11% rise, over the last year Mayne Pharma Ltd. has showed a 72.62% increase.
MAYNF net income for the last quarter is ‪−48.03 M‬ USD, while the quarter before that showed ‪−114.45 M‬ USD of net income which accounts for 58.03% change. Track more Mayne Pharma Ltd. financial stats to get the full picture.
Today Mayne Pharma Ltd. has the market capitalization of ‪392.39 M‬, it has decreased by 4.68% over the last week.
Like other stocks, MAYNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mayne Pharma Ltd. stock right from TradingView charts — choose your broker and connect to your account.
MAYNF reached its all-time high on Jun 29, 2016 with the price of 34.00 USD, and its all-time low was 1.90 USD and was reached on Oct 4, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mayne Pharma Ltd. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mayne Pharma Ltd. stock shows the buy signal. See more of Mayne Pharma Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Mayne Pharma Ltd. future price: according to them, MAYNF price has a max estimate of 4.82 USD and a min estimate of 4.37 USD. Read a more detailed Mayne Pharma Ltd. forecast: see what analysts think of Mayne Pharma Ltd. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Mayne Pharma Ltd. EBITDA is ‪−21.01 M‬ USD, and current EBITDA margin is −65.91%. See more stats in Mayne Pharma Ltd. financial statements.